Natural Cycles Wins Sixth FDA Clearance

Natural Cycles has secured another regulatory clearance for an algorithm designed to make fertility predictions more responsive to individual patterns.

What happened

The company received its sixth FDA clearance, covering a new fertility algorithm that combines statistical modelling with machine learning trained on tens of millions of data points.

The updated system is designed to refine predictions as it receives more information about an individual user’s cycle.

Why it matters

Consumer-health algorithms can directly influence personal decisions, so improvements must meet a higher standard than an ordinary software update. Regulatory clearance gives the company permission to introduce the new method while subjecting its claims to formal review.

The update also reflects a broader movement from fixed population-level assumptions toward models that adapt to individual health patterns.

The bigger picture

Digital-health products are increasingly combining consumer interfaces with regulated medical or health-related algorithms. Their advantage will depend not only on collecting more data, but on proving that personalised predictions are accurate, understandable and safe enough for real-world use.